Sofinnova Venture Partners IX L.P. 13D/13G Filings for Entasis Therapeutics Holdings Inc. (ETTX)

Sofinnova Venture Partners IX L.P. 13D and 13G filings for Entasis Therapeutics Holdings Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-03-04
06:17 am
Sale
2020-08-0613DEntasis Therapeutics Holdings Inc.
ETTX
Sofinnova Venture Partners IX L.P.0
0.000%
-1,180,178decrease
(Position Closed)
Filing